In brief
Based on the essays of Ezhil Ganesan (MU Plovdiv), improved and checked by AceMed
- Emergence is the return from general anaesthesia to consciousness after the agents are stopped: spontaneous breathing, airway reflexes, awareness, movement and pain return, neuromuscular blockade is reversed, and the patient is extubated.
- It is the reverse of induction, and the airway is as much at risk as at induction: laryngospasm, aspiration, residual paralysis, hypoxaemia and agitation are the main hazards, and extubation needs a clear plan.
- The patient leaves the operating room only when airway, breathing, circulation, consciousness, temperature, pain and nausea are all safe; a score such as the modified Aldrete (9 or more of 10) is used before leaving the recovery unit.
Emergence from general anaesthesia: phases
Emergence starts when the volatile agent or infusions are turned off (ideally with an opioid for analgesia and an antiemetic already given) and ends when the patient is awake, breathing adequately, protecting the airway and following commands. The patient passes back through the stages of anaesthesia in reverse (surgical anaesthesia, excitement/delirium, analgesia/sedation, awake), which is why airway reflexes are most irritable in the middle of the process.
Reversal of neuromuscular blockade
- Principle: quantitative monitoring is preferred; a train-of-four (TOF) ratio of at least 0.9 means adequate recovery. Clinical tests (head lift for 5 s, hand grip) are unreliable and spontaneous breathing alone is not enough: the diaphragm recovers earlier than the muscles of the airway and pharynx.
- Neostigmine (anticholinesterase) 50 µg/kg IV (up to 5 mg) with glycopyrronium 10 µg/kg (or atropine 20 µg/kg) to block muscarinic effects (bradycardia, salivation, bronchospasm); it needs at least a TOF count of 2 or more, has a ceiling effect and its effect is slow (10 minutes or more).
- Sugammadex reverses rocuronium (less strongly vecuronium) by encapsulating the steroidal molecule: 2 mg/kg for moderate block (TOF count 2 or more), 4 mg/kg for deep block (post-tetanic count 1–2), 16 mg/kg for immediate reversal after rocuronium 1.2 mg/kg. It does not reverse benzylisoquinoliniums (atracurium, cisatracurium) or suxamethonium. Rare anaphylaxis, bradycardia and a drug interaction with hormonal contraceptives (additional contraception advised) are recognised.
- Suxamethonium is not reversed; it wears off in 5–10 minutes (longer in plasma cholinesterase deficiency).